Warning-Alert: Job offer possible fraud warning
14/04/2022
OUR NEWS
21400
employees
150
countries in which
the Group’s medicines
are distributed
>20%
of brand-name revenue
invested in R&D every year
€ 4.9 billion euros
in 2021/2022 comprising €3.3 billion
for brand-name medicines and
€1.2 billion for generic medicines.
4 therapeutic areas
oncology,
immuno-inflammation,
cardiometabolism
and neuroscience
Latest posts on our social networks
Servier Medical Art is a medical image bank that we make available to illustrate your medical releases